November 8, 2024

Deviations will happen. Sooner or later, you will be faced with decisions about deviations. That’s why it’s important to have a deviation management system in place.

One of the key processes for achieving consistent pharmaceutical product quality is the management of these deviations. Any divergence from established procedures, specifications, or standards can have a significant impact on the quality of the product.

This is why the U.S. Food and Drug Administration (FDA) mandates strict adherence to good manufacturing practices (GMP), as outlined in 21 CFR Part 211—a comprehensive set of regulations governing the manufacture, processing, packing, or holding of drugs.

More about Deviations

Deviations occur when actual manufacturing processes do not follow standard operating procedures (SOPs) or when results differ from expected outcomes. These deviations could be minor, such as slight variations in environmental conditions, or major, such as errors in batch production that could compromise product safety or efficacy. Regardless of their scale, deviations must be addressed promptly and systematically.

Regulatory Requirements: 21 CFR Part 211

21 CFR Part 211 establishes the minimum GMP requirements for the preparation of drug products. This regulation mandates that all deviations be recorded and investigated to determine their cause, assess their potential impact, and implement corrective actions. Key sections of 21 CFR Part 211 that emphasize deviation documentation include:

• Section 211.192: This section requires the thorough investigation of any unexplained discrepancy or failure of a batch to meet specifications, whether the batch has been distributed or not. The investigation must include a written record of the findings and the corrective actions taken.
• Section 211.100: This section focuses on written production and process control procedures. It specifies that these procedures must be followed, and any deviation from the procedure must be documented and justified.
• Section 211.22: Under this section, the Quality Control unit is tasked with approving or rejecting all drug products and must ensure that any deviations in production are properly documented and reviewed.

Why is Managing Deviations Important?

1. Product Quality and Patient Safety.
2. Regulatory Compliance
3. Root Cause Analysis and Continuous Improvement
4. Audit Trail

Best Practices for Documenting Deviations

To effectively manage and document deviations, pharmaceutical companies should:

• Establish clear procedures for reporting deviations, including guidelines for classifying deviations based on their impact (critical, major, or minor).
• Ensure that all employees are trained to recognize deviations and understand the importance of documenting them.
• Use electronic batch records (EBRs) to capture and qualify deviations in real-time
• Conduct regular reviews of documented deviations to identify trends, underlying causes, and opportunities for process improvements.
• Provide traceability throughout the entire production process, to identify any material, equipment, or activity that could be responsible for the deviation.

In pharmaceutical manufacturing, some number of deviations is inevitable, but how they are handled determines the quality of the final product. By rigorously documenting and addressing deviations, pharmaceutical manufacturers can foster a culture of compliance, continuous improvement, and accountability. This will build trust with the medical community and regulators as well.

InstantGMP has designed a deviation management system to ensure that any changes in the production process are correctly tracked and executed.  We have designed this system with full compliance to 21 CFR Part 211. Our deviation system has integration to related workflows (Electronic Batch Records, CAPA, etc. ) for efficiency and minimal documentation error.

For more information on how our systems manage deviations, contact us